Diversified Trust Co Has $25.11 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Diversified Trust Co reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 47,939 shares of the healthcare conglomerate’s stock after selling 1,806 shares during the quarter. UnitedHealth Group comprises 0.6% of Diversified Trust Co’s holdings, making the stock its 25th largest holding. Diversified Trust Co’s holdings in UnitedHealth Group were worth $25,108,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG increased its holdings in UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after purchasing an additional 9,872 shares in the last quarter. Whipplewood Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $625,000. Finally, Heritage Investors Management Corp increased its stake in shares of UnitedHealth Group by 1.9% in the 4th quarter. Heritage Investors Management Corp now owns 68,313 shares of the healthcare conglomerate’s stock valued at $34,557,000 after acquiring an additional 1,262 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Barclays reduced their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research report on Monday, June 2nd. Oppenheimer dropped their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Finally, Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $415.57.

UnitedHealth Group Trading Up 0.1%

Shares of UnitedHealth Group stock opened at $302.43 on Friday. The company’s 50-day moving average price is $339.15 and its 200-day moving average price is $456.28. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market cap of $274.35 billion, a price-to-earnings ratio of 12.66, a PEG ratio of 1.43 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the company posted $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is 37.02%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares of the company’s stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last quarter. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.